Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside

被引：38
|
作者：
Furukawa, Toru [1 ]
机构：
[1] Tokyo Womens Med Univ, Int Res & Educ Inst Integrated Med Sci, Shinjuku Ku, Tokyo 1628666, Japan
来源：
JOURNAL OF GASTROENTEROLOGY | 2008年 / 43卷 / 12期
关键词：
pancreatic cancer; molecular targeting; RAS-MAPK; PI3K-AKT; hedgehog;
D O I：
10.1007/s00535-008-2226-1
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
Current medical interventions for pancreatic cancer are insufficient. Recent molecular investigations have elucidated complex genetic mechanisms of cancer that especially involve multiple signal transduction pathways; this enables us to develop molecular medicines targeting specific genetic molecules in the pathways. These molecular medicines seem to promise clues for curing cancers, including pancreatic cancer. This review describes current knowledge and perspectives regarding the development of molecular medicines for pancreatic cancer by focusing on growth factor receptor systems and three major signal transduction pathways: the RAS-MAPK, PI3K-AKT-mTOR, and hedgehog pathways.
引用
收藏
页码：905 / 911
页数：7
相关论文
共 50 条
  • [1] Molecular targeting therapy for pancreatic cancer: current knowledge and perspectives from bench to bedside
    Toru Furukawa
    Journal of Gastroenterology, 2008, 43 : 905 - 911
  • [2] Precision Therapy of Pancreatic Cancer: From Bench to Bedside
    Ciecielski, Katrin Jana
    Berninger, Alexandra
    Alguel, Hana
    VISCERAL MEDICINE, 2020, 36 (05) : 373 - 380
  • [3] Phospholipases in Gliomas: Current Knowledge and Future Perspectives from Bench to Bedside
    Marvi, Maria Vittoria
    Neri, Irene
    Evangelisti, Camilla
    Ramazzotti, Giulia
    Asioli, Sofia
    Zoli, Matteo
    Mazzatenta, Diego
    Neri, Niccolo
    Morandi, Luca
    Tonon, Caterina
    Lodi, Raffaele
    Franceschi, Enrico
    McCubrey, James A.
    Suh, Pann-Ghill
    Manzoli, Lucia
    Ratti, Stefano
    BIOMOLECULES, 2023, 13 (05)
  • [4] TARGETING REDOX METABOLISM FOR CANCER THERAPY: FROM THE BENCH TO THE BEDSIDE
    Spitz, Douglas
    FREE RADICAL BIOLOGY AND MEDICINE, 2017, 112 : 12 - 12
  • [5] Current Knowledge in Thyroid Cancer-From Bench to Bedside
    Grimm, Daniela
    INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2017, 18 (07)
  • [6] Pancreatic cancer: from bench to bedside
    Ma, Yaokai
    Wu, Qing
    Li, Xin
    Gu, Xiaoqiang
    Xu, Jiahua
    Yang, Jinzu
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (23)
  • [7] Molecular Pathology of Pancreatic Cancer: From Bench-to-Bedside Translation
    Corbo, Vincenzo
    Tortora, Giampaolo
    Scarpa, Aldo
    CURRENT DRUG TARGETS, 2012, 13 (06) : 744 - 752
  • [8] Pancreatic cancer from bench to bedside: molecular pathways and treatment options
    Kosmidis, Christoforos
    Sapalidis, Konstantinos
    Kotidis, Efstathios
    Mixalopoulos, Nikolaos
    Zarogoulidis, Paul
    Tsavlis, Drosos
    Baka, Sofia
    Man, Yan-Gao
    Kanellos, John
    ANNALS OF TRANSLATIONAL MEDICINE, 2016, 4 (09)
  • [9] Targeting the host in Pancreatic Cancer: A Novel Combination Therapeutic from Bench to Bedside
    Jones, Keaton
    Russell, Shannon
    O'Neill, Eric
    BRITISH JOURNAL OF SURGERY, 2023, 110
  • [10] Targeting Macrophages in Cancer: From Bench to Bedside
    Poh, Ashleigh R.
    Ernst, Matthias
    FRONTIERS IN ONCOLOGY, 2018, 8
12345